Startups channel feed

At Third Arc Bio, for­mer J&J lead­ers raise $165M to test on­col­o­gy, au­toim­mune bi­o­log­ics

11 months ago
Financing

Flag­ship launch­es AI-pow­ered bi­o­log­ics biotech with $50M back­ing

11 months ago
Financing
R&D

Health tech start­up Com­mure bets on AI for med­ical notes in $139M deal

11 months ago
Deals
AI

Where Oak HC/FT in­vestor Nan­cy Brown is plac­ing her bets on AI in health tech

11 months ago
AI
Health Tech

Or­biMed forms biotech with as­sets from Chi­na-based Keymed, en­lists for­mer Bio­haven ex­ec as CEO

11 months ago
Financing
China

Arti­va's IPO rais­es $167M to fund com­pa­ny's au­toim­mune and can­cer cell ther­a­pies

11 months ago
Financing
Cell/Gene Tx

Ex­clu­sive: TM­RW Life Sci­ences rais­es $28M Se­ries D to up­grade stor­age for egg freez­ing

11 months ago
Financing
Health Tech

Thyme Care scores $480M val­u­a­tion in new fund­ing round

11 months ago
Financing
Health Tech

Q&A: Jef­feries an­a­lyst Bri­an Tan­quilut talks Wal­greens’ re­treat from pri­ma­ry care and what’s sink­ing re­tail­ers’ health­care bets

11 months ago
Health Tech

Scor­pi­on rais­es $150M with sights on the next wave of tar­get­ed ther­a­pies

11 months ago
Financing

Sion­na li­cens­es clin­i­cal-stage cys­tic fi­bro­sis as­sets from Ab­b­Vie short­ly af­ter large Se­ries C

11 months ago
Deals
Pharma

Bain-backed Car­du­ri­on rais­es $260M to fund ex-Imara drug, buy more car­dio as­sets

11 months ago
Financing

Af­ter last year's Im­muno­Gen pact, Ver­tex finds an­oth­er con­di­tion­ing agent part­ner in Orum

11 months ago
Deals
Cell/Gene Tx

Alzheimer's biotech As­ceneu­ron rais­es $100M to see if it can com­pete with Lil­ly, Bio­gen on tau

11 months ago
Financing

Ex­clu­sive: Kins rais­es $7M to ex­pand in-home and vir­tu­al phys­i­cal ther­a­py

12 months ago
Financing
Health Tech

Metageno­mi sci­ence chief de­parts, just a few months af­ter IPO

12 months ago
People

Spin­outs, pen­sion re­forms and a GSK vet in cab­i­net: What the new UK gov­ern­ment could mean for life sci­ences

12 months ago
Financing

Flag­ship's Noubar Afeyan on un­cer­tain­ty, AI and biotech’s fu­ture

Last year
Financing

Up­dat­ed: Flag­ship reels in $3.6B to cre­ate 25 new com­pa­nies

Last year
Financing

Are 'next-gen' biotech ac­quir­ers ex­pe­ri­enc­ing their mo­ment?

Last year
Deals
Pharma

Ex­clu­sive: Couri­er Health rais­es $16.5M Se­ries A to help bio­phar­ma com­pa­nies bring to­geth­er pa­tient da­ta

Last year
Health Tech

Bio­vance de­buts with €51M to lift up biotech scene in Por­tu­gal and south­ern Eu­rope

Last year
Financing

Ex­clu­sive: Gene in­ser­tion start­up launch­es with new in­te­grase tech­nol­o­gy from Uni­ver­si­ty of Hawaii

Last year
Financing
Cell/Gene Tx

VC firm emerges to boost Aus­tri­an biotech scene that’s ‘ready to break out’

Last year
Financing
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times